diabetestalk.net

Latent Autoimmune Diabetes Symptoms

I've Been Diagnosed With Lada — Latent Autoimmune Diabetes In Adults. What's The Difference Between It And Other Forms Of Diabetes?

I've Been Diagnosed With Lada — Latent Autoimmune Diabetes In Adults. What's The Difference Between It And Other Forms Of Diabetes?

Latent autoimmune diabetes in adults (LADA) is a slow progressing form of autoimmune diabetes. Like the autoimmune disease type 1 diabetes, LADA occurs because your pancreas stops producing adequate insulin, most likely from some "insult" that slowly damages the insulin-producing cells in the pancreas. But unlike type 1 diabetes, with LADA, you often won't need insulin for several months up to years after you've been diagnosed. Many researchers believe LADA, sometimes called type 1.5 diabetes, is a subtype of type 1 diabetes. Other researchers believe diabetes occurs on a continuum, with LADA falling between type 1 and type 2 diabetes. People who have LADA are usually over age 30. Because they're older when symptoms develop than is typical for someone with type 1 diabetes and because initially their pancreases still produce some insulin, people with LADA are often misdiagnosed with type 2 diabetes. If you've been diagnosed with type 2 diabetes and you're lean and physically active or you've recently lost weight without effort, talk with your doctor about whether your current treatment is still the best one for you. At first, LADA can be managed by controlling your blood sugar with diet, weight reduction if appropriate, exercise and, possibly, oral medications. But as your body gradually loses its ability to produce insulin, insulin shots will eventually be needed. More research is needed before the best way to treat LADA is established. Talk with your doctor about the best LADA treatment options for you. As with any type of diabetes, you'll need close follow-up to minimize progression of your diabetes and potential complications. Continue reading >>

Latent Autoimmune Diabetes In Adults

Latent Autoimmune Diabetes In Adults

Latent autoimmune diabetes in adults (LADA) is a slowly progressive form of autoimmune diabetes mellitus characterized by older age at diagnosis, the presence of pancreatic autoantibodies, and the lack of an absolute insulin requirement at diagnosis. Although patients with LADA present with more preserved beta cell function than those with classic type 1 diabetes, they tend to have a rapid and progressive loss of beta cell function necessitating intensive insulin intervention. Family physicians care for most patients in the United States with type 2 diabetes and, therefore, should be aware that approximately 10 percent of these patients have LADA.1 Table 1 compares characteristics of type 1 diabetes, type 2 diabetes, and LADA.2 Features Type 2 diabetes Type 1 diabetes [ corrected] Latent autoimmune diabetes in adults [ corrected] Ketoacidosis Usually absent Will develop rapidly unless patient receives insulin replacement therapy Absent at diagnosis, but may be present when patient becomes severely insulinopenic Cardiovascular complications Risk 2–4 times higher than individuals who are euglycemic Increased risk of cardiovascular morbidity and mortality related to strokes, acute coronary events, and coronary revascularizations; high incidence rates compared with euglycemic individuals, especially in women Same risk as patients with T2DM Microvascular complications (retinopathy, nephropathy, neuropathy) Increased Increased Increased Pathophysiology Peripheral insulin resistance; reduced pancreatic beta-cell mass and function; reduced insulin secretion Autoimmune destruction of pancreatic beta-cells Latent autoimmune destruction of pancreatic beta-cells Autoantibodies Negative GAD-65 autoantibodies Islet-cell antigen-2 Insulin autoantibodies note: Unlike LADA, T1DM patie Continue reading >>

Lada- Latent Autoimmune Diabetes Of The Adult

Lada- Latent Autoimmune Diabetes Of The Adult

A proportion of patients ranging from 5-20% with a clinical diagnosis of type 2 diabetes have been found to possess islet autoantibodies, most typically GADA, and patients in this category progress more rapidly to insulin treatment. This is referred to as Latent Autoimmune Diabetes of the Adult (LADA) and occurs in individuals with a clinical phenotype resembling type 2 diabetes. Immunologically LADA is characterized by islet directed autoantibodies and is considered a form of type 1 diabetes. People with LADA do not require insulin for the first 3 to 6 months following diagnosis, but up to 80% will require insulin within the next five years. Some physicians treat LADA electively with insulin before metabolic decompensation has occurred, but the evidence for this is contested and most patients are treated according to standard management guidelines for type 2 diabetes. Continue reading >>

Lada And Gad: Diagnosing Type 1.5 Diabetes

Lada And Gad: Diagnosing Type 1.5 Diabetes

Researchers in Germany have further endorsed the effectiveness of a blood test that helps determine whether some adult diabetics diagnosed as type 2 diabetes are actually in the early stages of having type 1 diabetes. Latent Autoimmune Diabetes of Adults (LADA) like type 1 diabetes, is an autoimmune response that that destroys insulin-producing beta cells in the pancreas. It is often misdiagnosed as type 2 diabetes because it looks and acts a lot like type 2– arising usually in adulthood and progressing slowly– but, unlike type 2 diabetes, LADA results from the autoimmune destruction of insulin-producing beta cells. A test for glutamic acid decarboxylase, or GAD, antibodies, has long been used as a method of differentiating between LADA (which is sometimes referred to at type 1.5 diabetes) and type 2 diabetes in people over age 30. With LADA as well as type 1 diabetes, the body’s immune system begins to attack its own beta cells. When the immune system attacks pathogens, one weapon in its arsenal is the creation of antibodies that bind to the foreign objects and mark them as invaders. In the case of autoimmune diabetes, the body begins to create antibodies against parts of proteins that are not foreign, but rather are associated with its own beta cells. GAD is one of the earliest proteins to be targeted by antibodies, and so by testing for the presence of GAD antibodies, doctors can determine whether there is an autoimmune reaction to beta cells taking place. “At diagnosis, people with LADA usually do not require insulin right away because they are still producing some insulin,” according to Christy L. Parkin, MSN, RN, CDE, Associate Editor of Diabetes Forecast. “Because of their older age, they are often misdiagnosed as type 2 and started on oral medication Continue reading >>

Latent Autoimmune Diabetes In Adults (lada)

Latent Autoimmune Diabetes In Adults (lada)

Type 1 diabetes diagnosed in adulthood may be a form of slowly-progressing diabetes called latent autoimmune diabetes in adults (LADA). LADA is also known as slow-onset type 1 diabetes, type 1.5 diabetes, late-onset autoimmune diabetes of adulthood, and even “double diabetes,” since it has elements of both type 1 and type 2 diabetes. LADA patients, however, are closer to type 1 patients, because they will test positive for antibodies against insulin-producing beta cells of the pancreas. LADA is more common than classic childhood type 1 diabetes, and is similar to type 1 diabetes, but presents more slowly—and therefore does not require insulin therapy as early in the course of treatment. Most LADA patients do eventually require insulin; the key difference between LADA and type 1 diabetes is not the age of disease onset, but rather the progression of the disease. People with type 1 diabetes tend to be completely insulin-dependent within a few months of diagnosis, while people with LADA can sometimes survive for years without needing to take insulin. Because they still produce some insulin, and because the disease usually occurs in people over the age of thirty without severe symptoms, many LADA patients are initially misdiagnosed with type 2 diabetes. In fact, researchers estimate that up to 10 percent of people diagnosed with type 2 diabetes have LADA. LADA can be distinguished from type 2 diabetes by antibody tests. Patients who are antibody-positive have an autoimmune reaction similar to that of type 1 diabetes, but which is not found in type 2 diabetes. Researchers still don’t know whether autoimmune diabetes in adults is due to the same underlying disease process as type 1 diabetes in children, and there are many LADA questions that still need answers. In an Continue reading >>

Latent Autoimmune Diabetes Of Adults

Latent Autoimmune Diabetes Of Adults

Latent autoimmune diabetes of adults (LADA) is a form of diabetes mellitus type 1 that occurs in adulthood, often with a slower course of onset than type 1 diabetes diagnosed in juveniles.[3] Adults with LADA may initially be diagnosed incorrectly as having type 2 diabetes based on their age, particularly if they have risk factors for type 2 diabetes such as a strong family history or obesity. The diagnosis is typically based on the finding of hyperglycemia together with the clinical impression that islet failure rather than insulin resistance is the main cause; detection of a low C-peptide and raised antibodies against the islets of Langerhans support the diagnosis. It can only be treated with the usual oral treatments for type 2 diabetes for a certain period of time,[4][5] after which insulin treatment is usually necessary, as well as long-term monitoring for complications. The concept of LADA was first introduced in 1993,[6] though The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus does not recognize the term, instead including it under the standard definition of diabetes mellitus type 1.[7] Signs and symptoms[edit] The symptoms of latent autoimmune diabetes of adults are similar to those of other forms of diabetes: polydipsia (excessive thirst and drinking), polyuria (excessive urination), and often blurred vision.[8] Compared to juvenile type 1 diabetes, the symptoms develop comparatively slowly, over a period of at least six months.[9] Diagnosis[edit] It is estimated that more than 50% of persons diagnosed as having non-obesity-related type 2 diabetes may actually have LADA. Glutamic acid decarboxylase autoantibody (GADA), islet cell autoantibody (ICA), insulinoma-associated (IA-2) autoantibody, and zinc transporter autoantibody (ZnT8) t Continue reading >>

Emotional Exhaustion-induced Latent Autoimmune Diabetes In Adults In A Young Lady

Emotional Exhaustion-induced Latent Autoimmune Diabetes In Adults In A Young Lady

Go to: Abstract Latent autoimmune diabetes in adults (LADA) refers to an autoimmune disorder characterized with detectable islets antibodies in the early diagnosis and increased autoimmune beta-cell failure progression. Notably, this kind of diabetes seems to be confused with other phenotypic diabetes. A young woman suffered an emotional exhaustion-induced LADA, showing asthenia, polydipsia, polyuria, and visible weight loss. The patient emotionally ended a 14-year romantic relationship, leading to the emotional flooding. The data from physical examination and laboratory tests exhibited as follows: glutamic acid decarboxylase antibody (GADA) = 63.83 U/mL, the fasting blood glucose (FBG) = 13.3 mmol/L, and glycated haemoglobin (HbA1c) = 10.9%. According to levels of GADA, the patient was diagnosed as LADA. Interventions: The patient was clinically treated with insulin for 3-month. Then, running, diet-control, and emotional treatment were combined, such as the patient started a new relationship. An emotional recovery initiated from a new romantic relationship and a baby, showing normal levels of GAD65 (27.007 IU/mL) and FBG (5.46) mmol/L. The emotional exhaustion might play a significant role in induction of LADA. It is important that individuals should maintain optimism, cheer, and a positive attitude. Keywords: emotional exhaustion, GADA, latent autoimmune diabetes in adults Continue reading >>

How Is Latent Autoimmune Diabetes In Adults Best Diagnosed And Treated?

How Is Latent Autoimmune Diabetes In Adults Best Diagnosed And Treated?

Q: What is latent autoimmune diabetes in adults (LADA)? A: In LADA, patients appear to have type 2 diabetes phenotypically. They do not, however, have an early requirement for insulin. They are also positive for autoantibodies usually associated with type 1 diabetes. When compared to those with type 1 diabetes, these patients generally have greater preservation of ß-cell function with a slower development of absolute insulin deficiency; however, they do invariably develop a need for insulin.1 The proposed diagnostic criteria for LADA include: 1) Adult age at diagnosis (usually ≥30). 2) Positivity for at least one antibody usually seen in type 1 diabetes including islet cell autoantigen-2 antibodies, islet cell antibodies, insulin antibodies, and glutamic acid decarboxylase 65 antibodies (anti-GAD). 3) Evidence of at least temporary preservation of ß-cells with a delay in the need for insulin therapy at least 6 months after initial diagnosis.2 These patients usually will require insulin within 6 years of diagnosis as ß-cells fail with the autoimmune pancreatic effects. Q: Should I check antibody levels on all new onset adult patients with diabetes to evaluate for the presence of LADA? A: No. LADA accounts for approximately 10% of cases of diabetes in adults.3 In a majority of patients presenting in the ambulatory setting, the determination of type 1 versus type 2 diabetes is often based on the clinical presentation at diagnosis. However, in patients where the diagnosis is not clear—eg, patients who have little evidence of insulin resistance but whose apparent type 2 diabetes is controlled by oral medications or those who are of normal weight, have an active lifestyle, and do not have a family history of diabetes—checking antibodies is a reasonable approach to he Continue reading >>

Type 1.5 Diabetes: An Overview

Type 1.5 Diabetes: An Overview

Type 1.5 Diabetes (T1.5D) is also known as Latent Autoimmune Diabetes of Adults (LADA). LADA is considered by some experts to be a slowly progressive form of Type 1 Diabetes (T1D) while other experts in the field consider it a separate form of Diabetes. LADA or T1.5D is sometimes thought of as T1D that is diagnosed in adults over the age of 30—T1D is commonly diagnosed in children and younger adults. T1.5D is often found along with Type 2 Diabetes (T2D): up to 25% of individuals with T1.5D also have characteristics of T2D.1 This is sometimes called “double diabetes”. Individuals with T1.5D are all eventually dependent on insulin for treatment, and have a very high risk of requiring insulin within months or years (up to six years) after the initial diagnosis. This is in contrast to people with T1D—these people tend to need insulin within days or weeks of diagnosis.2 Individuals diagnosed with T2D relatively rarely require insulin treatment. Current recommendations are to treat individuals with T1.5D immediately with insulin, though this is not universally accepted (see below). The Causes of T1.5D Just as with other forms of diabetes, we don’t truly understand the underlying cause(s) of T1.5D. There are autoimmune components in Types 1, 1.5 and 2 diabetes with some overlap in the types of antibodies formed, so it is clear that as in T1D, the immune system has become “confused” and begins to act against the beta cells of the pancreas—the source of the insulin needed to control blood sugars. Both T1D and T1.5D have antibodies to glutamic acid decarboxylase or anti-GAD antibodies. As with T1D, individuals with T1.5D tend not to be obese, whereas in T2D, most individuals are overweight or obese. Genetics and Environmental Susceptibility Individuals with T1.5D Continue reading >>

Latent Autoimmune Diabetes Of The Adult: Current Knowledge And Uncertainty

Latent Autoimmune Diabetes Of The Adult: Current Knowledge And Uncertainty

Go to: Patients with adult-onset autoimmune diabetes have less Human Leucocyte Antigen (HLA)-associated genetic risk and fewer diabetes-associated autoantibodies compared with patients with childhood-onset Type 1 diabetes. Metabolic changes at diagnosis reflect a broad clinical phenotype ranging from diabetic ketoacidosis to mild non-insulin-requiring diabetes, also known as latent autoimmune diabetes of the adult (LADA). This latter phenotype is the most prevalent form of adult-onset autoimmune diabetes and probably the most prevalent form of autoimmune diabetes in general. Although LADA is associated with the same genetic and immunological features as childhood-onset Type 1 diabetes, it also shares some genetic features with Type 2 diabetes, which raises the question of genetic heterogeneity predisposing to this form of the disease. The potential value of screening patients with adult-onset diabetes for diabetes-associated autoantibodies to identify those with LADA is emphasized by their lack of clinically distinct features, their different natural history compared with Type 2 diabetes and their potential need for a dedicated management strategy. The fact that, in some studies, patients with LADA show worse glucose control than patients with Type 2 diabetes, highlights the need for further therapeutic studies. Challenges regarding classification, epidemiology, genetics, metabolism, immunology, clinical presentation and treatment of LADA were discussed at a 2014 workshop arranged by the Danish Diabetes Academy. The presentations and discussions are summarized in this review, which sets out the current ideas and controversies surrounding this form of diabetes. What’s new? Latent autoimmune diabetes of the adult (LADA) is an autoimmune diabetes defined by adult-onset, Continue reading >>

Latent Autoimmune Diabetes In Adults

Latent Autoimmune Diabetes In Adults

Reviewed by endocrinologist Stanley S. Schwartz, MD, emeritus Associate Professor of Medicine at the University of Pennsylvania and George Grunberger, MD, FACP, FACE, Chairman of the Grunberger Diabetes Institute, Clinical Professor of Internal Medicine and Molecular Medicine & Genetics at Wayne State University School of Medicine and President of the American Association of Clinical Endocrinologists Call it diabetes type 1.5. Double diabetes. Or “slim type 2.” By any name, LADA—latent autoimmune diabetes in adults—plays by its own rules. Similar to type 1 diabetes, in LADA the immune system attacks and destroys insulin-making beta cells in the pancreas. But it progresses more slowly than type 1. Like type 2, it tends to happen after age 30. That’s just one reason LADA is usually misdiagnosed as type 2. Like typical type 2s, people with LADA may be insulin resistant; their bodies don’t respond readily to insulin’s signals to absorb blood sugar. And LADA can usually be controlled for months or years with pills and other non-insulin blood-sugar medications used by type 2s. But eventually, people with LADA need daily insulin shots or a pump to control their blood sugar.1 Researchers are still delving into LADA’s true nature. Some experts think it’s simply slow-motion type 1. Others have a hunch LADA’s got its own unique genetic signature.2 Up to 10% of people with type 2 may have LADA. “Knowing you have LADA could help your doctor choose early medications that can preserve beta cells longer. And it could help you and your doctor move you to insulin therapy sooner when blood sugar levels rise,” explains endocrinologist Stanley S. Schwartz, MD, an emeritus Associate Professor of Medicine at the University of Pennsylvania. Is it LADA? Blood glucose tes Continue reading >>

A Clinical Screening Tool Identifies Autoimmune Diabetes In Adults

A Clinical Screening Tool Identifies Autoimmune Diabetes In Adults

Abstract OBJECTIVE—Latent autoimmune diabetes in adults (LADA) is defined as adult-onset diabetes with circulating islet antibodies but not requiring insulin therapy initially. Diagnosing LADA has treatment implications because of the high risk of progression to insulin dependency. Currently, there are no recommendations for islet antibody testing in adult-onset diabetes. In this study, we aimed to develop a clinical screening tool to identify adults at high risk of LADA who require islet antibody testing. RESEARCH DESIGN AND METHODS—Subjects with LADA (n = 102, GAD antibody [GADA]+) and type 2 diabetes (n = 111, GADA−) (aged 30–75 years) were interviewed retrospectively. The clinical features documented were age of onset, acute symptoms of hyperglycemia, BMI, and personal and family history of autoimmune disease. Any clinical feature that was significantly more frequent in LADA was designated as a distinguishing clinical feature. In each subject, a “LADA clinical risk score,” based on the total number of distinguishing features, was calculated. A prospective study of adults with newly diagnosed diabetes (n = 130) was used to determine whether the LADA clinical risk score could identify LADA. RESULTS—In the retrospective study, five clinical features were more frequent in LADA compared with type 2 diabetes at diagnosis: 1) age of onset <50 years (P < 0.0001), 2) acute symptoms (P < 0.0001), 3) BMI <25 kg/m2 (P = 0.0004), 4) personal history of autoimmune disease (P = 0.011), and 5) family history of autoimmune disease (P = 0.024). In the prospective study, the presence of at least two of these distinguishing clinical features (LADA clinical risk score ≥2) had a 90% sensitivity and 71% specificity for identifying LADA and a negative predictive value for a Continue reading >>

What Is Lada?

What Is Lada?

LADA isn’t the newest version of a hot coffee and milk beverage; rather it stands for latent autoimmune diabetes in adults. You may not have heard of it—it isn’t as common as type 2 diabetes or gestational diabetes, or even regular type 1 diabetes— but physicians have been familiar with it for a while. Like type 1 diabetes, LADA involves the almost complete destruction of the beta producing insulin cells by the body’s own immune system. Some researchers categorize LADA as a subset of type 1 diabetes, while others think of it as simply a way station in the continuum between type 1 diabetes and type 2 diabetes. Other scientists do not believe it is a separate disease at all. For them, type 1 diabetes has many different expressions and LADA is simply one of them. Interestingly enough, LADA was discovered by scientists looking at ways to test for auto-antibodies in the blood of people with diabetes. When they tested the blood of people with type 2 diabetes, they found that about ten percent of them carried insulin antibodies. Insulin antibodies are usually found in people with type 1 diabetes. Since type 2 diabetes isn’t an autoimmune disease, these folks had “something” different. In fact, they would go on to need full insulin replacement even though in other ways they resembled the profile of someone with type 2 diabetes. These slow starters were named LADA. What some people believe makes LADA different from type 1 diabetes is the delay in the need for insulin replacement and the age of the population who contracts it. For most people with type 1 diabetes the need for insulin replacement is abrupt. Once symptoms such as polyuria, polydipsia and polyphagia appear insulin is needed, even if the disease was years in the making. LADA is slow-moving. Sometimes Continue reading >>

Latent Autoimmune Diabetes In Adults: Signs, Symptoms And Treatment

Latent Autoimmune Diabetes In Adults: Signs, Symptoms And Treatment

What is Latent Autoimmune Diabetes in Adults? LADA, or latent autoimmune diabetes in adults, is a form of type 1 diabetes (T1D) which develops slowly into adulthood. Unlike a typical T1D diagnosis, when you are diagnosed with LADA, you will not require insulin therapy right away. LADA occurs when the immune system mistakenly attacks and destroys the beta cells in the pancreas, just like in type 1 diabetes except it occurs later in life. As a result, the pancreas cannot produce insulin. Insulin is responsible for storing and processing glucose for the body tissues to use as energy. Glucose is a form of sugar which is one of the main sources of fuel for your body. When you eat foods that are rich in carbohydrates, glucose is absorbed into the bloodstream. Without insulin, glucose cannot enter the body’s cells for energy. Hence, they stay in the bloodstream and build up. Excess glucose in the bloodstream can become dangerous, leading to life threatening complications. However, compared to type 1 diabetes in children, LADA develops more slowly. While T1D develops quickly in children, sometimes within a few days or weeks, symptoms of LADA can take years to develop. This condition can first appear to be type 2 diabetes (T2D), thus LADA might be mistakenly diagnosed for T2D. T2D is a chronic medical condition where the body becomes resistant to insulin. Like T2D, latent autoimmune diabetes in adults develops over a longer time period compared to T1D in young adults and children. Sometimes, LADA is called type 1.5 diabetes. Although this is not an official name, it shows that LADA is a form of T1D, which has the same characteristics as T2D. Initially, people with LADA can rely on diet, exercise, weight control and oral medication to manage their blood sugar levels. However, w Continue reading >>

Diabetes Lada

Diabetes Lada

Tweet LADA stands for Latent Autoimmune Diabetes of Adulthood. LADA is a form of type 1 diabetes that develops later into adulthood. LADA tends to develop more slowly than type 1 diabetes in childhood and, because LADA can sometimes appear similar to type 2 diabetes, doctors may mistakenly diagnose LADA as type 2 diabetes. The definition provided by Prof. David Leslie, Principle Investigator of Action LADA, is that in Europe: LADA is defined as initially non-insulin requiring diabetes diagnosed in people aged 30-50 years with antibodies to GAD - glutamic acid decarboxylase. How does LADA compare with other diabetes types? LADA is sometimes referred to as type 1.5 diabetes. This is not an official term but it does illustrate the fact that LADA is a form of type 1 diabetes that shares some characteristics with type 2 diabetes. As a form of type 1 diabetes, LADA is an autoimmune disease in which the body’s immune system attacks and kills off insulin producing cells. The reasons why LADA can often be mistaken for type 2 diabetes is it develops over a longer period of time than type 1 diabetes in children or younger adults. Whereas type 1 diabetes in children tends to develop quickly, sometimes within the space of days, LADA develops more slowly, sometimes over a period of years. The slower onset of diabetes symptoms being presented in people over 35 years may lead a GP to initially diagnose a case of LADA as type 2 diabetes. Symptoms of LADA The first symptoms of LADA include: Feeling tired all the time or regularly tired after meals Foggy headedness Experiencing hunger soon after meals As LADA develops, a person’s ability to produce insulin will gradually decrease and this may lead to symptoms such as: It is important to catch the symptoms at the earliest stage because Continue reading >>

More in diabetes